Grenier B, Hamza B, Biron G, Xueref C, Viarme F, Roumiantzeff M
Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S545-7. doi: 10.1093/clinids/6.supplement_2.s545.
An inactivated poliovirus vaccine prepared from cultures of Vero cells has been tested on 61 infants from two to 11 months of age (mean age, 4.3 months) for tolerance and serologic potency. Three doses of vaccine were given one month apart at the same time that diphtheria-tetanus-pertussis vaccine was injected at another body site. Poliovirus-neutralizing antibody titers were measured before the first and third injections and one month after each. The titer was considered positive when the dilution was greater than or equal to 1:4. The tolerance has been good. Thirty-one infants were assessable for serologic efficacy; all had significant serologic responses after two injections of polio vaccine, regardless of the titer of maternally transmitted antibodies before the immunizations. The third injection did not significantly increase the antibody titer observed after the first two doses.
一种由Vero细胞培养物制备的灭活脊髓灰质炎疫苗,已在61名年龄在2至11个月(平均年龄4.3个月)的婴儿身上进行了耐受性和血清学效力测试。在另一个身体部位注射白喉-破伤风-百日咳疫苗的同时,每隔一个月接种三剂疫苗。在第一次和第三次注射前以及每次注射后一个月测量脊髓灰质炎病毒中和抗体滴度。当稀释度大于或等于1:4时,滴度被视为阳性。耐受性良好。31名婴儿可评估血清学疗效;无论免疫前母体传播抗体的滴度如何,所有婴儿在两次注射脊髓灰质炎疫苗后均有显著的血清学反应。第三次注射并未显著提高在前两剂后观察到的抗体滴度。